Examples of Performance-based Agreements and Recent HTA Outcomes for Novel Therapies
Risk-sharing agreements (RSAs), especially performance-based, are only growing in popularity among payers, health technology assessment (HTA) agencies, and manufacturers, as they provide common grounds to make new medicines (even more for high-cost ones) available to patients that otherwise wouldn’t be at the time of product launch when limited real-world data are available. HTA outcomes help […]